Comparing Acute and Continuous Drug Abuse Treatment: A Randomized Clinical Trial

Completed · Phase 3

Conditions studied: Drug Addiction

In brief

The purpose of this 2 year study is to conduct a fully powered effectiveness trial comparing recovery trajectories of 200 drug dependent adults (the subjects) who will be randomly assigned to Treatment as Usual (TAU) or TAU + Long-Term Recovery Management (LTRM).

Key facts

Study ID

NCT01003496

Run by

Wright State University

People needed

204

Starts

2009-11-05

Expected to finish

2011-07-27

Last updated by the study team

2022-03-09

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• To be eligible for the study, a subject must:
• At least 18 years of age
• Meet current dependence criteria for stimulants (cocaine/other), opioids (heroin/other), and/or alcohol (if also dependent on cocaine or opioids). Persons who are opioid dependent are eligible if they are not in methadone maintenance therapy; they will be eligible if they are in short-term buprenorphine detoxification
• Self-report use of a primary drug of dependence in the past 60 days; 4) be admitted to outpatient care at Maryhaven
• Willing to participate in the protocol (i.e., to be randomized to treatment condition and agree to attend regular treatment sessions).

You may not qualify if…

• Potential subjects will be excluded if they: 1) present with current suicide risk
• Have a current, untreated psychotic disorder
• Plan to relocate outside of the area within 12 months
• Have been sentenced to incarceration of more than 30 days over the next 6 months
• Are alcohol dependent without current dependence on cocaine or opioids.

Where it is running

• Maryhaven — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.